Menu
GeneBe

SLC5A6

solute carrier family 5 member 6, the group of Solute carrier family 5

Basic information

Region (hg38): 2:27199586-27212958

Links

ENSG00000138074NCBI:8884OMIM:604024HGNC:11041Uniprot:Q9Y289AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • neurodegeneration, infantile-onset, biotin-responsive (Strong), mode of inheritance: AR
  • inherited neurodegenerative disorder (Moderate), mode of inheritance: AR
  • neurodegeneration, infantile-onset, biotin-responsive (Moderate), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Neurodegeneration, infantile-onset, biotin-responsive; Sodium-dependent multivitamin transporter deficiencyARBiochemicalIndividuals with Neurodegeneration, infantile-onset, biotin-responsive may respond to biotin, as well as other medical treatments; Sodium-dependent multivitamin transporter deficiency is a multisystem metabolic disorder, and medical/dietary treatment (with biotin, pantothenic acid, and alpha-lipoic acid) has been shown to result in clinical improvementBiochemical; Neurologic27904971; 31392107; 31754459; 35013551

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SLC5A6 gene.

  • Inborn genetic diseases (27 variants)
  • not provided (22 variants)
  • Neurodegeneration, infantile-onset, biotin-responsive (10 variants)
  • Peripheral motor neuropathy, childhood-onset, biotin-responsive (4 variants)
  • SLC5A6-related disorder (2 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC5A6 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
4
clinvar
7
missense
1
clinvar
25
clinvar
10
clinvar
2
clinvar
38
nonsense
3
clinvar
3
start loss
0
frameshift
3
clinvar
3
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
clinvar
2
splice region
0
non coding
1
clinvar
1
Total 4 6 25 13 6

Highest pathogenic variant AF is 0.0000986

Variants in SLC5A6

This is a list of pathogenic ClinVar variants found in the SLC5A6 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
2-27200457-G-C Inborn genetic diseases Uncertain significance (Sep 06, 2022)2357705
2-27200464-G-T Inborn genetic diseases Uncertain significance (Apr 22, 2022)2284798
2-27200477-CCT-C Neurodegeneration, infantile-onset, biotin-responsive • Peripheral motor neuropathy, childhood-onset, biotin-responsive Likely pathogenic (Feb 08, 2023)1341577
2-27201024-G-A Inborn genetic diseases Uncertain significance (Jan 30, 2024)3165272
2-27201040-C-T Benign (Dec 26, 2018)787001
2-27201042-G-A Inborn genetic diseases Uncertain significance (Nov 14, 2023)3165271
2-27201088-G-T Inborn genetic diseases Uncertain significance (Aug 23, 2021)2246663
2-27201104-C-T Neurodegeneration, infantile-onset, biotin-responsive Likely benign (Aug 12, 2021)713562
2-27201355-A-G Inborn genetic diseases Uncertain significance (Feb 28, 2024)3165270
2-27201359-G-C Inborn genetic diseases Likely benign (Dec 28, 2022)3165269
2-27201380-C-A Inborn genetic diseases Uncertain significance (Apr 05, 2023)2533500
2-27201669-G-A Inborn genetic diseases Uncertain significance (Oct 10, 2023)3165268
2-27201709-C-T Inborn genetic diseases Uncertain significance (Sep 22, 2023)3165267
2-27201735-C-T Benign (Dec 26, 2018)788951
2-27201750-G-A Inborn genetic diseases Likely benign (Jan 04, 2022)2390909
2-27201755-G-C Likely benign (Jun 13, 2018)750724
2-27201768-G-A Benign (Jul 02, 2020)1256723
2-27201771-C-T Inborn genetic diseases Uncertain significance (Jan 10, 2022)3165266
2-27201778-T-G Inborn genetic diseases Uncertain significance (Sep 12, 2023)2591910
2-27201784-C-T Inborn genetic diseases Uncertain significance (Nov 21, 2022)2225835
2-27201785-G-A Benign (Apr 05, 2018)716281
2-27201796-T-C Inborn genetic diseases Uncertain significance (Feb 21, 2024)3165265
2-27201796-T-G Inborn genetic diseases Uncertain significance (Nov 29, 2023)3165264
2-27201806-GA-G Neurodegeneration, infantile-onset, biotin-responsive Likely pathogenic (Aug 02, 2023)2627917
2-27201817-C-A Inborn genetic diseases Likely benign (Dec 13, 2023)3165263

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SLC5A6protein_codingprotein_codingENST00000310574 1513372
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.006080.9941256990491257480.000195
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.632913800.7650.00002194060
Missense in Polyphen72135.160.532711405
Synonymous0.2071551580.9790.000009401385
Loss of Function3.611032.00.3120.00000175326

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002960.000296
Ashkenazi Jewish0.00009920.0000992
East Asian0.0001630.000163
Finnish0.00004620.0000462
European (Non-Finnish)0.0002460.000246
Middle Eastern0.0001630.000163
South Asian0.0001960.000196
Other0.0003260.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Transports pantothenate, biotin and lipoate in the presence of sodium.;
Pathway
Vitamin digestion and absorption - Homo sapiens (human);Nuclear Receptors Meta-Pathway;NRF2 pathway;Biotin transport and metabolism;Vitamin B5 - CoA biosynthesis from pantothenate;Metabolism;Vitamin B5 (pantothenate) metabolism;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Transport of small molecules;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Lipoate metabolism;Vitamin H (biotin) metabolism (Consensus)

Intolerance Scores

loftool
0.125
rvis_EVS
-0.09
rvis_percentile_EVS
47.06

Haploinsufficiency Scores

pHI
0.280
hipred
N
hipred_score
0.476
ghis
0.471

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.504

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Slc5a6
Phenotype
behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); digestive/alimentary phenotype; limbs/digits/tail phenotype; skeleton phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype;

Gene ontology

Biological process
sodium ion transport;biotin transport;pantothenate transmembrane transport
Cellular component
plasma membrane;integral component of plasma membrane;vesicle membrane;membrane;brush border membrane
Molecular function
sodium-dependent multivitamin transmembrane transporter activity